04/29/2025
4:00 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form DEF 14A | |
04/14/2025
4:05 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form PRE 14A | |
03/20/2025
3:05 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:34 PM | ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
10:22 AM | Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Kirk Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Robinson James A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Lee June (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Katkin Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ELDN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
McBride John S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:30 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Hillson Jan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
7:00 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:51 PM | ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/12/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
3:17 PM | Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
11/05/2024
10:44 AM | Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G | |
10/31/2024
4:52 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
4:49 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
4:50 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/30/2024
5:36 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 424B5 | |
10/30/2024
5:24 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 424B5 | |
10/29/2024
8:27 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:00 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
11:15 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
09/20/2024
4:00 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:16 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/19/2024
3:33 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q/A | |
08/19/2024
3:36 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024
3:30 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-K/A | |
08/14/2024
4:12 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/14/2024
4:15 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
3:30 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:47 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
URGENT: Someone's Moving Gold Out of London... (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong…
They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.  Go here to learn about my Top Four picks for the coming bull mania. |
07/10/2024
3:41 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
11:15 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form EFFECT | |
05/24/2024
3:02 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/22/2024
6:36 PM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
05/15/2024
6:00 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
4:04 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:15 AM | Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ELDN Stock Free ELDN Stock Alerts